The family of Milagros Larosa sued GlaxoSmithKline (GSK), claiming its diabetes drug Avandia was responsible for Larosa’s fatal stroke in December 2005. The Larosas accused GSK of causing her wrongful death due to negligence, breach of warranty, fraud, and failing to warn about the risks of Avandia. In November 2007, the Food and Drug Administration (FDA) announced a second “black box” warning would be added to the Avandia label advising users of its cardiovascular risks. In 2008, Larosa’s case was transferred to a federal court in Pennsylvania and consolidated with a national class action. In May 2010, it was reported that GlaxoSmithKline settled with more than 700 plaintiffs for $60 million. In July 2010, it was reported that GSK settled approximately 10,000 additional lawsuits for $460 million. In February 2011, it was reported that GSK settled 5,500 additional lawsuits for $250 million. In February 2012, it was reported that GSK settled more than 20,000 more cases for an undisclosed amount.